Portal de Periódicos da CAPES

Normalization of Cytoplasmic Calcium Response in Pancreatic β-Cells of Spontaneously Diabetic GK Rat by the Treatment with T-1095, a Specific Inhibitor of Renal Na+-Glucose Co-Transporters

2002; Thieme Medical Publishers (Germany); Volume: 34; Issue: 4 Linguagem: Inglês

10.1055/s-2002-26714

1439-4286

Koichiro Yasuda, Y. Okamoto, Kiyohide Nunoi, Tetsuya Adachi, Nobuyuki Shihara, Akiko Tamon, Noboru Suzuki, Eri Mukai, Shimpei Fujimoto, Akira Oku, K. Tsuda, Y. Seino,

Pancreatitis Pathology and Treatment

Chronic hyperglycemia is known to lead to a progressively further impaired insulin response and to hasten the development of complications in patients with type 2 diabetes, a notion referred as glucose toxicity. T-1095, a derivative of phlorizin, is a newly developed oral hypoglycemic agent that acts as a specific inhibitor of renal Na(+)-glucose co-transporters, reducing circulating blood glucose levels by promoting glucose excretion into urine. The effects of glycemic improvement by T-1095 on secretory function and cytoplasmic calcium response in pancreatic beta-cells were investigated using spontaneously diabetic GK rats. After four weeks of treatment with T-1095 (age 4 to 8 week rats), serum glucose and HbA1c levels were significantly improved (serum glucose level, GK vs. GK T-1095, 277.3 +/- 11.8 vs. 204.7 +/- 6.4 mg/dl; HbA1c level, GK vs. GK T-1095, 6.2 +/- 0.2 vs. 4.8 +/- 0.1 %). Insulin secretion induced by 16.7 mM glucose was also significantly increased in the T-1095-treated group compared to the untreated group. The [Ca(2+)]i response induced by 16.7 mM glucose in GK beta-cells was characterized by the loss of the steep first peak of [Ca(2+)]i elevation, and the lost first peak of [Ca(2+)]i reappeared in T-1095-treated beta-cells in 32 of 34 observations. In T-1095-treated beta-cells, the time lag to peak [Ca(2+)]i levels in the 16.7 mM glucose stimulation was significantly reduced (259.1 +/- 15.3 sec, p < 0.01) compared to untreated GK rats (524.7 +/- 52.9 sec). Thus, improvement of hyperglycemia by T-1095 ameliorates beta-cell function by relieving [Ca(2+)]i response.